+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 0 - 39Years
All Genders
ID06796543

Radiation Therapy Targeting Metastatic Sites in Children and Young Adults With Soft Tissue and Bone Sarcoma

Led by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Updated on 2026-07-13

70

Participants Needed

3

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to improve overall survival for children, adolescents, and young adults with metastatic soft tissue and bone sarcoma by targeting metastatic sites with radiation therapy. The study focuses on consolidative radiation therapy cRT after standard chemotherapy in this population, addressing gaps left by prior adult-focused studies. It also explores circulating tumor DNA as a potential biomarker to track response and provide additional prognostic information. Participants are assigned to one of two groups Stratum A, which receives standard chemotherapy followed by consolidative radiation to the primary tumor and all metastatic sites, and Stratum B, which receives standard second-line systemic therapy with radiation to at least one metastatic site. The study is a single-arm, non-randomized phase II trial designed to enroll 32 evaluable patients under age 39. During the study, participants undergo standard chemotherapy and restaging imaging before radiation treatment. Researchers will monitor event-free survival and overall survival over two years to evaluate the impact of consolidative radiation. Feasibility of tracking circulating tumor DNA throughout treatment will also be assessed. The trial includes ongoing evaluations of disease progression, imaging, and survival outcomes over the study period ending in 2030.

CONDITIONS

Brief Title

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Research Team

S

Sahaja Acharya, MD

C

Colette Youstra, MSPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here